Global Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
The Global Topical Corticosteroids Market is accounted to reach USD 4,440.38 million by 2024, from USD 2,828.36 million in 2016 growing at a CAGR of 5.8% in the forecast period 2017 to 2024.
The factors such as increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.
The key market players for Global Topical Corticosteroids Market are listed below:
Based on molecule name, global topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others.
In 2017, Fludroxycortide is expected to dominate the Global topical corticosteroids market with 26.2% market share and is expected to reach USD 229.42 million by 2024, growing at a CAGR of 7.2% in the forecast period 2017 to 2024. However, betamethasone is expected to grow at the highest CAGR of 7.5% in the forecast period, and is expected to reach USD 173.58 million in 2024 from USD 97.14 million in 2016.
Based on purchase mode, global topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, the prescription based market segment is expected to account for the largest share of 72.1% of the global topical corticosteroids market, by purchase mode. This segment is expected to grow at the highest CAGR of 6.1% in the forecast period 2017 to 2024.
The global topical corticosteroids market, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
Based on application, global topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, the psoriasis is one of the dominating sectors of global topical corticosteroids market with 40.5% market share, growing at the highest CAGR 6.5% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments is expected to dominate the global topical corticosteroids market with 31.2% market share and is expected to reach USD 1,344.11 million by 2024, with a CAGR of 5.4% in the forecast period 2017 to 2024. However lotions is expected to grow at the highest CAGR of 7.1% in the forecast period, to reach USD 510.50 million by 2024 from USD 294.87 million in 2016 in the forecast period 2017 to 2024.
The Global topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, the moderate potency class market segment is expected to account for the largest share of 41.0% of the global topical corticosteroids market, by potency class. This segment is expected to grow at the highest CAGR of 6.4% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, the dermatology clinics market segment is expected to account for the largest share of 43.5% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
The Global topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, the pharmacies stores market segment is expected to account for the largest share of 46.3% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.5% in the forecast period 2017 to 2024.
Based on geography, the Global Topical Corticosteroids market is segmented into 11 geographical regions, such as,
The report covers the present scenario and the growth prospects of the Global Topical Corticosteroids market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The factors such as increasing prevalence of chronic disease or condition, rise in aging population, growth in topical drug delivery, increasing research and development, new product launches are furthermore boosting the growth of the global topical corticosteroids market.
The key market players for Global Topical Corticosteroids Market are listed below:
- LEO Pharma,
- Glaxosmithkline Plc
- and Pfizer Inc.
- Type
- Application
- End User
- Geography
Based on molecule name, global topical corticosteroids market is segmented into fludroxycortide, triamcinolone acetonide, fluocinolone acetonide, antiseptics, betamethasone, clobetasone propionate, clobetasone butyrate, halobetasone, mometasone, and others.
In 2017, Fludroxycortide is expected to dominate the Global topical corticosteroids market with 26.2% market share and is expected to reach USD 229.42 million by 2024, growing at a CAGR of 7.2% in the forecast period 2017 to 2024. However, betamethasone is expected to grow at the highest CAGR of 7.5% in the forecast period, and is expected to reach USD 173.58 million in 2024 from USD 97.14 million in 2016.
Based on purchase mode, global topical corticosteroids market is segmented into segmented into OTC-based and prescription-based. In 2017, the prescription based market segment is expected to account for the largest share of 72.1% of the global topical corticosteroids market, by purchase mode. This segment is expected to grow at the highest CAGR of 6.1% in the forecast period 2017 to 2024.
The global topical corticosteroids market, on the basis of brands is segmented into betnovate, betnovate N, panderm plus, lobate, cosvate G, clop G, tenovate GN, lobate GM, ultiderm, flutivate, fexin, momate, candiderm, and others.
Based on application, global topical corticosteroids market is segmented into acne, dermatitis, psoriasis, skin infection, hyperpigmentation, melasma and others. In 2017, the psoriasis is one of the dominating sectors of global topical corticosteroids market with 40.5% market share, growing at the highest CAGR 6.5% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on medication type into ointments, creams, liquid & solutions, lotions, gel, oils, pastes, sprays, and others. In 2017, ointments is expected to dominate the global topical corticosteroids market with 31.2% market share and is expected to reach USD 1,344.11 million by 2024, with a CAGR of 5.4% in the forecast period 2017 to 2024. However lotions is expected to grow at the highest CAGR of 7.1% in the forecast period, to reach USD 510.50 million by 2024 from USD 294.87 million in 2016 in the forecast period 2017 to 2024.
The Global topical corticosteroids market is segmented based on potency class into moderate, mild, ultra-high, and high. In 2017, the moderate potency class market segment is expected to account for the largest share of 41.0% of the global topical corticosteroids market, by potency class. This segment is expected to grow at the highest CAGR of 6.4% in the forecast period 2017 to 2024.
The global topical corticosteroids market is segmented based on end-user into three notable segments; hospital, dermatology clinics, homecare and others. In 2017, the dermatology clinics market segment is expected to account for the largest share of 43.5% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.6% in the forecast period 2017 to 2024.
The Global topical corticosteroids market is segmented based on distribution channel into four notable segments; hospital pharmacies, pharmacy stores, online pharmacies and others. In 2017, the pharmacies stores market segment is expected to account for the largest share of 46.3% of the global topical corticosteroids market. This segment is expected to grow at the highest CAGR of 6.5% in the forecast period 2017 to 2024.
Based on geography, the Global Topical Corticosteroids market is segmented into 11 geographical regions, such as,
- North America,
- South America,
- Europe,
- APAC,
- MEA,
- Rest Of the World
The report covers the present scenario and the growth prospects of the Global Topical Corticosteroids market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL TOPICAL CORTICOSTEROIDS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT
3.1.5. NEW PRODUCT LAUNCHES BY KEY PLAYERS
3.2. RESTRAINTS
3.2.1. EXPIRY OF PATENT FOR DRUGS
3.2.2. WEAK REIMBURSEMENT POLICIES
3.2.3. STRINGENT REGULATORY POLICIES
3.3. OPPORTUNITIES
3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET
3.3.3. INCREASING MERGERS AND ACQUISITIONS
3.4. CHALLENGES
3.4.1. PRICING PRESSURE BY GOVERNMENT
3.4.2. SIDE EFFECTS OF TOPICAL CORTICOSTEROIDS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME
6.1. OVERVIEW
6.2. FLUDROXYCORTIDE
6.3. TRIAMCINOLONE ACETONIDE
6.4. FLUOCINOLONE ACETONIDE
6.5. ANTISEPTICS
6.6. BETAMETHASONE
6.7. CLOBETASONE PROPIONATE
6.8. CLOBETASONE BUTYRATE
6.9. HALOBETASONE
6.10. MOMETASONE
6.11. OTHERS
7. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS
7.1. OVERVIEW
7.2. ULTRA HIGH
7.2.1. CLOBETASOL PROPIONATE
7.2.2. DIFLORASONE DIACETATE
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL
7.3. HIGH
7.3.1. AMCINONIDE
7.3.2. BETAMETHASONE DIPROPIONATE
7.3.3. DESOXIMETASONE
7.3.4. FLUOCINONIDE
7.3.5. OTHERS
7.4. MODERATE
7.4.1. DESOXIMETASONE
7.4.2. FLUOCINOLONE ACETONIDE
7.4.3. FLUDROXYCORTIDE
7.4.4. HYDROCORTISONE VALERATE
7.4.5. TRIAMCINOLONE ACETONIDE
7.4.6. CLOBETASONE BUTYRATE
7.4.7. OTHERS
7.5. MILD
7.5.1. HYDROCORTISONE
7.5.2. HYDROCORTISONE ACETATE
7.5.3. BETAMETHASONE VALERATE
7.5.4. DESONIDE
7.5.5. FLUOCINOLONE ACETONIDE
7.5.6. OTHERS
8. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. ACNE
8.3. DERMATITIS
8.4. PSORIASIS
8.5. SKIN INFECTION
8.6. HYPERPIGMENTATION
8.7. MELASMA
8.8. OTHERS
9. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE
9.1. OVERVIEW
9.2. OINTMENTS
9.3. CREAMS
9.4. LIQUID & SOLUTIONS
9.5. LOTIONS
9.6. GEL
9.7. OILS
9.8. PASTES
9.9. SPRAYS
9.10. OTHERS
10. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER
10.1. OVERVIEW
10.2. HOSPITAL
10.3. DERMATOLOGY CLINICS
10.4. HOMECARE
10.5. OTHERS
11. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL
11.1. OVERVIEW
11.2. HOSPITAL PHARMACIES
11.3. PHARMACY STORES
11.4. ONLINE PHARMACIES
11.5. OTHERS
12. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE
12.1. OVERVIEW
12.2. OVER THE COUNTER (OTC) BASED
12.3. PRESCRIPTION BASED
13. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS
13.1. OVERVIEW
13.2. BETNOVATE
13.3. BETNOVATE N
13.4. PANDERM PLUS
13.5. LOBATE
13.6. COSVATE G
13.7. CLOP G
13.8. TENOVATE GN
13.9. LOBATE GM
13.10. ULTIDERM
13.11. FLUTIVATE
13.12. FEXIN
13.13. MOMATE
13.14. CANDIDERM
13.15. OTHERS
14. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO
14.3. EUROPE
14.3.1. GERMANY
14.3.2. FRANCE
14.3.3. U.K.
14.3.4. ITALY
14.3.5. SPAIN
14.3.6. RUSSIA
14.3.7. TURKEY
14.3.8. BELGIUM
14.3.9. NETHERLANDS
14.3.10. SWITZERLAND
14.3.11. REST OF EUROPE
14.4. ASIA-PACIFIC
14.4.1. JAPAN
14.4.2. CHINA
14.4.3. INDIA
14.4.4. SOUTH KOREA
14.4.5. AUSTRALIA
14.4.6. SINGAPORE
14.4.7. THAILAND
14.4.8. MALAYSIA
14.4.9. INDONESIA
14.4.10. PHILIPPINES
14.4.11. REST OF ASIA PACIFIC
14.5. SOUTH AMERICA
14.5.1. BRAZIL
14.5.2. REST OF SOUTH AMERICA
14.6. MIDDLE EAST AND AFRICA
14.6.1. SOUTH AFRICA
14.6.2. REST OF MIDDLE EAST AND AFRICA
15. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
16. COMPANY PROFILES
16.1. GLAXOSMITHKLINE PLC.
16.1.1. COMPANY OVERVIEW
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS
16.1.3. PRODUCT PORTFOLIO
16.1.4. RECENT DEVELOPMENTS
16.2. MERCK & CO. INC.
16.2.1. COMPANY OVERVIEW
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. LEO PHARMA
16.3.1. COMPANY OVERVIEW
16.3.2. LEO PHARMA: REVENUE ANALYSIS
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. ALMIRALL S.A.
16.4.1. COMPANY OVERVIEW
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT
16.4.3. PRODUCT PORTFOLIO
16.4.4. RECENT DEVELOPMENTS
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL
16.5.1. COMPANY OVERVIEW
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS
16.5.3. PRODUCT PORTFOLIO
16.5.4. RECENT DEVELOPMENTS
16.6. ZYLERA PHARMACEUTICALS
16.6.1. COMPANY OVERVIEW
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. SANDOZ INTERNATIONAL GMBH
16.7.1. COMPANY OVERVIEW
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC.: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. SANOFI S.A.
16.9.1. COMPANY OVERVIEW
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. ASTRAZENECA
16.10.1. COMPANY OVERVIEW
16.10.2. ASTRAZENECA: REVENUE ANALYSIS
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL TOPICAL CORTICOSTEROIDS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT
3.1.5. NEW PRODUCT LAUNCHES BY KEY PLAYERS
3.2. RESTRAINTS
3.2.1. EXPIRY OF PATENT FOR DRUGS
3.2.2. WEAK REIMBURSEMENT POLICIES
3.2.3. STRINGENT REGULATORY POLICIES
3.3. OPPORTUNITIES
3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET
3.3.3. INCREASING MERGERS AND ACQUISITIONS
3.4. CHALLENGES
3.4.1. PRICING PRESSURE BY GOVERNMENT
3.4.2. SIDE EFFECTS OF TOPICAL CORTICOSTEROIDS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME
6.1. OVERVIEW
6.2. FLUDROXYCORTIDE
6.3. TRIAMCINOLONE ACETONIDE
6.4. FLUOCINOLONE ACETONIDE
6.5. ANTISEPTICS
6.6. BETAMETHASONE
6.7. CLOBETASONE PROPIONATE
6.8. CLOBETASONE BUTYRATE
6.9. HALOBETASONE
6.10. MOMETASONE
6.11. OTHERS
7. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS
7.1. OVERVIEW
7.2. ULTRA HIGH
7.2.1. CLOBETASOL PROPIONATE
7.2.2. DIFLORASONE DIACETATE
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL
7.3. HIGH
7.3.1. AMCINONIDE
7.3.2. BETAMETHASONE DIPROPIONATE
7.3.3. DESOXIMETASONE
7.3.4. FLUOCINONIDE
7.3.5. OTHERS
7.4. MODERATE
7.4.1. DESOXIMETASONE
7.4.2. FLUOCINOLONE ACETONIDE
7.4.3. FLUDROXYCORTIDE
7.4.4. HYDROCORTISONE VALERATE
7.4.5. TRIAMCINOLONE ACETONIDE
7.4.6. CLOBETASONE BUTYRATE
7.4.7. OTHERS
7.5. MILD
7.5.1. HYDROCORTISONE
7.5.2. HYDROCORTISONE ACETATE
7.5.3. BETAMETHASONE VALERATE
7.5.4. DESONIDE
7.5.5. FLUOCINOLONE ACETONIDE
7.5.6. OTHERS
8. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. ACNE
8.3. DERMATITIS
8.4. PSORIASIS
8.5. SKIN INFECTION
8.6. HYPERPIGMENTATION
8.7. MELASMA
8.8. OTHERS
9. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE
9.1. OVERVIEW
9.2. OINTMENTS
9.3. CREAMS
9.4. LIQUID & SOLUTIONS
9.5. LOTIONS
9.6. GEL
9.7. OILS
9.8. PASTES
9.9. SPRAYS
9.10. OTHERS
10. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER
10.1. OVERVIEW
10.2. HOSPITAL
10.3. DERMATOLOGY CLINICS
10.4. HOMECARE
10.5. OTHERS
11. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL
11.1. OVERVIEW
11.2. HOSPITAL PHARMACIES
11.3. PHARMACY STORES
11.4. ONLINE PHARMACIES
11.5. OTHERS
12. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE
12.1. OVERVIEW
12.2. OVER THE COUNTER (OTC) BASED
12.3. PRESCRIPTION BASED
13. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS
13.1. OVERVIEW
13.2. BETNOVATE
13.3. BETNOVATE N
13.4. PANDERM PLUS
13.5. LOBATE
13.6. COSVATE G
13.7. CLOP G
13.8. TENOVATE GN
13.9. LOBATE GM
13.10. ULTIDERM
13.11. FLUTIVATE
13.12. FEXIN
13.13. MOMATE
13.14. CANDIDERM
13.15. OTHERS
14. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY
14.1. OVERVIEW
14.2. NORTH AMERICA
14.2.1. U.S.
14.2.2. CANADA
14.2.3. MEXICO
14.3. EUROPE
14.3.1. GERMANY
14.3.2. FRANCE
14.3.3. U.K.
14.3.4. ITALY
14.3.5. SPAIN
14.3.6. RUSSIA
14.3.7. TURKEY
14.3.8. BELGIUM
14.3.9. NETHERLANDS
14.3.10. SWITZERLAND
14.3.11. REST OF EUROPE
14.4. ASIA-PACIFIC
14.4.1. JAPAN
14.4.2. CHINA
14.4.3. INDIA
14.4.4. SOUTH KOREA
14.4.5. AUSTRALIA
14.4.6. SINGAPORE
14.4.7. THAILAND
14.4.8. MALAYSIA
14.4.9. INDONESIA
14.4.10. PHILIPPINES
14.4.11. REST OF ASIA PACIFIC
14.5. SOUTH AMERICA
14.5.1. BRAZIL
14.5.2. REST OF SOUTH AMERICA
14.6. MIDDLE EAST AND AFRICA
14.6.1. SOUTH AFRICA
14.6.2. REST OF MIDDLE EAST AND AFRICA
15. GLOBAL TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE
15.1. COMPANY SHARE ANALYSIS: GLOBAL
15.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3. COMPANY SHARE ANALYSIS: EUROPE
15.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
16. COMPANY PROFILES
16.1. GLAXOSMITHKLINE PLC.
16.1.1. COMPANY OVERVIEW
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS
16.1.3. PRODUCT PORTFOLIO
16.1.4. RECENT DEVELOPMENTS
16.2. MERCK & CO. INC.
16.2.1. COMPANY OVERVIEW
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS
16.2.3. PRODUCT PORTFOLIO
16.2.4. RECENT DEVELOPMENTS
16.3. LEO PHARMA
16.3.1. COMPANY OVERVIEW
16.3.2. LEO PHARMA: REVENUE ANALYSIS
16.3.3. PRODUCT PORTFOLIO
16.3.4. RECENT DEVELOPMENTS
16.4. ALMIRALL S.A.
16.4.1. COMPANY OVERVIEW
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT
16.4.3. PRODUCT PORTFOLIO
16.4.4. RECENT DEVELOPMENTS
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL
16.5.1. COMPANY OVERVIEW
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS
16.5.3. PRODUCT PORTFOLIO
16.5.4. RECENT DEVELOPMENTS
16.6. ZYLERA PHARMACEUTICALS
16.6.1. COMPANY OVERVIEW
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT
16.6.3. PRODUCT PORTFOLIO
16.6.4. RECENT DEVELOPMENTS
16.7. SANDOZ INTERNATIONAL GMBH
16.7.1. COMPANY OVERVIEW
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.7.3. PRODUCT PORTFOLIO
16.7.4. RECENT DEVELOPMENTS
16.8. PFIZER INC.
16.8.1. COMPANY OVERVIEW
16.8.2. PFIZER INC.: REVENUE ANALYSIS
16.8.3. PRODUCT PORTFOLIO
16.8.4. RECENT DEVELOPMENTS
16.9. SANOFI S.A.
16.9.1. COMPANY OVERVIEW
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS
16.9.3. PRODUCT PORTFOLIO
16.9.4. RECENT DEVELOPMENTS
16.10. ASTRAZENECA
16.10.1. COMPANY OVERVIEW
16.10.2. ASTRAZENECA: REVENUE ANALYSIS
16.10.3. PRODUCT PORTFOLIO
16.10.4. RECENT DEVELOPMENTS
17. RELATED REPORTS
LIST OF TABLES AND FIGURES
Table 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS
Table 2 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 3 GLOBAL FLUDROXYCORTIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 4 GLOBAL TRIAMCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 5 GLOBAL FLUOCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 6 GLOBAL ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 7 GLOBAL BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 8 GLOBAL CLOBETASONE PROPIONATE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 9 GLOBAL CLOBETASONE BUTYRATE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 10 GLOBAL HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 11 GLOBAL MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 12 GLOBAL OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 13 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 14 GLOBAL ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 15 GLOBAL ULTRA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 16 GLOBAL HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 17 GLOBAL HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 18 GLOBAL MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 19 GLOBAL MODERATE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 20 GLOBAL MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 21 GLOBAL MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 22 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 23 GLOBAL ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 24 GLOBAL DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 25 GLOBAL PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 26 GLOBAL SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 27 GLOBAL HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 28 GLOBAL MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 29 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET, BY REGION, 2015 – 2024 (USD BILLION)
Table 30 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015– 2024 (USD MILLION)
Table 31 GLOBAL OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 32 GLOBAL CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 33 GLOBAL LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 34 GLOBAL LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 35 GLOBAL GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 36 GLOBAL OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 37 GLOBAL PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 38 GLOBAL SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 39 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 40 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015– 2024 (USD MILLION)
Table 41 GLOBAL HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 42 GLOBAL DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 43 GLOBAL HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 44 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 45 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
Table 46 GLOBAL HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 47 GLOBAL PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 48 GLOBAL ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 49 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 50 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 51 GLOBAL OVER THE COUNTER (OTC)BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 52 GLOBAL PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,BY REGION, 2015 – 2024 (USD MILLION)
Table 53 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 54 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION)
Table 55 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 56 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 57 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 58 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 59 NORTH AMERICA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 60 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 61 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 62 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 63 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 64 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 65 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 66 U.S. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 67 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 68 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 69 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 70 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 71 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 72 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 73 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 74 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 75 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 76 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 77 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 78 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 79 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 80 MEXICO TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 81 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 82 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 83 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION)
Table 84 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 85 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 86 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 87 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 88 EUROPE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 89 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 90 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 91 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 92 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 93 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 94 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 95 GERMANY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 96 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 97 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 98 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 99 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 100 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 101 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 102 FRANCE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 103 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 104 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 105 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 106 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 107 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 108 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 109 U.K. TOPICAL CONTORTIONISTS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 110 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 111 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 112 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 113 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 114 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 115 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 116 ITALY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 117 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 118 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 119 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 120 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 121 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 122 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 123 SPAIN TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 124 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 125 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 126 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 127 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 128 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 129 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 130 RUSSIA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 131 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 132 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 133 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 134 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 135 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 136 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 137 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 138 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 139 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 140 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 141 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 142 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 143 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 144 BELGIUM TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 145 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 146 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 147 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 148 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 149 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 150 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 151 NETHERLANDS TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 152 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 153 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 154 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 155 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 156 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 157 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 158 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 159 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 160 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 161 REST OF EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 162 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 163 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 164 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 165 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 166 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 167 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 168 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 169 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 170 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 171 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 172 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 173 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 174 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 175 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 176 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 177 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 178 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 179 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 180 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 181 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 182 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 183 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 184 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 185 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 186 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 187 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 188 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 189 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 190 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 191 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 192 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 193 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 194 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 195 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 196 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 197 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 198 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 199 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 200 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 201 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 202 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 203 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 204 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 205 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 206 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 207 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 208 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 209 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 210 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 211 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 212 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 213 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 214 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 215 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 216 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 217 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 218 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 219 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 220 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 221 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 222 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 223 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 224 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 225 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 226 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 227 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 228 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 229 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 230 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 231 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 232 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 233 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 234 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 235 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 236 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 237 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 238 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 239 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 240 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 241 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION)
Table 242 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 243 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 244 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 245 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 246 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 247 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 248 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 249 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 250 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 251 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 252 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 253 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 254 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 255 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 256 REST OF SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 257 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION)
Table 258 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 259 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 260 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 261 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 262 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 263 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION)
Table 264 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 265 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 266 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 267 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 268 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 269 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 270 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION)
Table 271 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 272 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS
Table 2 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 3 GLOBAL FLUDROXYCORTIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 4 GLOBAL TRIAMCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 5 GLOBAL FLUOCINOLONE ACETONIDE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 6 GLOBAL ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 7 GLOBAL BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 8 GLOBAL CLOBETASONE PROPIONATE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 9 GLOBAL CLOBETASONE BUTYRATE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 10 GLOBAL HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 11 GLOBAL MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 12 GLOBAL OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION)
Table 13 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 14 GLOBAL ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 15 GLOBAL ULTRA HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 16 GLOBAL HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 17 GLOBAL HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 18 GLOBAL MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 19 GLOBAL MODERATE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 20 GLOBAL MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 21 GLOBAL MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION)
Table 22 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 23 GLOBAL ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 24 GLOBAL DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 25 GLOBAL PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 26 GLOBAL SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 27 GLOBAL HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 28 GLOBAL MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 29 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET, BY REGION, 2015 – 2024 (USD BILLION)
Table 30 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015– 2024 (USD MILLION)
Table 31 GLOBAL OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 32 GLOBAL CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 33 GLOBAL LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 34 GLOBAL LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 35 GLOBAL GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 36 GLOBAL OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 37 GLOBAL PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 38 GLOBAL SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 39 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 40 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015– 2024 (USD MILLION)
Table 41 GLOBAL HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 42 GLOBAL DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 43 GLOBAL HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 44 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 45 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION)
Table 46 GLOBAL HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 47 GLOBAL PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 48 GLOBAL ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 49 GLOBAL OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015 – 2024 (USD MILLION)
Table 50 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 51 GLOBAL OVER THE COUNTER (OTC)BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION)
Table 52 GLOBAL PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,BY REGION, 2015 – 2024 (USD MILLION)
Table 53 GLOBAL TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 54 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION)
Table 55 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 56 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 57 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 58 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 59 NORTH AMERICA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 60 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 61 NORTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 62 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 63 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 64 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 65 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 66 U.S. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 67 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 68 U.S. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 69 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 70 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 71 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 72 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 73 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 74 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 75 CANADA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 76 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 77 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 78 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 79 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 80 MEXICO TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 81 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 82 MEXICO TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 83 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015– 2024 (USD MILLION)
Table 84 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 85 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 86 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 87 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 88 EUROPE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 89 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 90 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 91 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 92 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 93 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 94 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 95 GERMANY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 96 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 97 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 98 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 99 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 100 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 101 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 102 FRANCE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 103 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 104 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 105 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 106 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 107 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 108 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 109 U.K. TOPICAL CONTORTIONISTS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 110 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 111 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 112 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 113 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 114 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 115 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 116 ITALY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 117 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 118 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 119 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 120 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 121 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 122 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 123 SPAIN TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 124 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 125 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 126 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 127 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 128 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 129 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 130 RUSSIA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 131 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 132 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 133 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 134 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 135 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 136 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 137 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 138 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 139 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 140 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 141 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 142 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 143 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 144 BELGIUM TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 145 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 146 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 147 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 148 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 149 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 150 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 151 NETHERLANDS TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 152 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 153 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 154 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 155 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION)
Table 156 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 157 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 158 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION)
Table 159 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 160 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 161 REST OF EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION)
Table 162 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
Table 163 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 164 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 165 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 166 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 167 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 168 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 169 ASIA-PACIFIC TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 170 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 171 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 172 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 173 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 174 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 175 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 176 JAPAN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 177 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 178 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 179 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 180 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 181 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 182 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 183 CHINA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 184 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 185 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 186 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 187 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 188 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 189 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 190 INDIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 191 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 192 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 193 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 194 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 195 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 196 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 197 SOUTH KOREA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 198 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 199 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 200 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 201 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 202 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 203 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 204 AUSTRALIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 205 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 206 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 207 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 208 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 209 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 210 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 211 SINGAPORE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 212 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 213 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 214 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 215 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 216 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 217 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 218 THAILAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 219 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 220 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 221 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 222 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 223 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 224 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 225 MALAYSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 226 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 227 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 228 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 229 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 230 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 231 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 232 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 233 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 234 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015 – 2024 (USD MILLION)
Table 235 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
Table 236 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015 – 2024 (USD MILLION)
Table 237 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015 – 2024 (USD MILLION)
Table 238 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015 – 2024 (USD MILLION)
Table 239 PHILIPPINES TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION)
Table 240 INDONESIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015 – 2024 (USD MILLION)
Table 241 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION)
Table 242 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 243 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 244 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 245 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 246 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 247 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 248 SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 249 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 250 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 251 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 252 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 253 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 254 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY END USER, 2015-2024 (USD MILLION)
Table 255 BRAZIL TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 256 REST OF SOUTH AMERICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 257 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY, 2015-2024,(USD MILLION)
Table 258 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 259 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 260 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 261 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 262 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 263 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION)
Table 264 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 265 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
Table 266 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015-2024 (USD MILLION)
Table 267 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION, 2015-2024 (USD MILLION)
Table 268 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION)
Table 269 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015-2024 (USD MILLION)
Table 270 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY END-USER, 2015-2024 (USD MILLION)
Table 271 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION)
Table 272 SOUTH AFRICA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015-2024 (USD MILLION)
